Approval · Notice of Compliance 14191 · 2013
INTANZA: Notice of Compliance 14191
Issued March 8, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14191
- Date
- March 8, 2013
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of building 14
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTANZA | Not yet assigned | — |
Medicinal ingredients
- HAEMAGGLUTININ-STRAIN A(H1N1) 15 MCG per 0.1ML
- HAEMAGGLUTININ-STRAIN A(H3N2) 15 MCG per 0.1ML
- HAEMAGGLUTININ-STRAIN B 15 MCG per 0.1ML
- HAEMAGGLUTININ-STRAIN A(H1N1) 9 MCG per 0.1ML
- HAEMAGGLUTININ-STRAIN A(H3N2) 9 MCG per 0.1ML
- HAEMAGGLUTININ-STRAIN B 9 MCG per 0.1ML